Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Academic Article

• Overview
• Research
• Identity
• Additional Document Info
• View All

Overview

authors

• Graff, J. N.
• Alumkal, J. J.
• Drake, C. G.
• Thomas, G. V.
• Redmond, William
• Farhad, M.
• Cetnar, J. P.
• Ey, F. S.
• Bergan, R. C.
• Slottke, R.
• Beer, T. M.

publication date

• August 2016

journal

• Oncotarget  Journal

subject areas

• Aged
• Aged, 80 and over
• Antibodies, Monoclonal, Humanized
• Antineoplastic Combined Chemotherapy Protocols
• Drug Administration Schedule
• Drug Resistance, Neoplasm
• Humans
• Hypothyroidism
• Male
• Middle Aged
• Myositis
• Neoplasm Metastasis
• Phenylthiohydantoin
• Programmed Cell Death 1 Receptor
• Prostate-Specific Antigen
• Prostatic Neoplasms, Castration-Resistant
• Remission Induction

Research

keywords

• Immune response
• Immunity
• Immunology and Microbiology Section
• PD-1
• enzalutamide
• immunotherapy
• prostate cancer

Identity

PubMed Central ID

• PMC5288150

International Standard Serial Number (ISSN)

• 1949-2553

Digital Object Identifier (DOI)

• 10.18632/oncotarget.10547

PubMed ID

• 27429197

Additional Document Info

start page

• 52810

end page

• 52817

volume

• 7

issue

• 33